Nobleoak Life (ASX:NOL) Research & Development: A$0.0 Mil (TTM As of Dec. 2025)


ASX:NOL Nobleoak Life Ltd ASX:NOL
52 GF Score
Price A$1.19
GF Value A$1.76
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Nobleoak Life Research & Development?

Nobleoak Life ASX:NOL -7.42% 52 Research & Development is A$0.0 Mil as of Dec. 2025. GuruFocus rates ASX:NOL with a GF Score™ of 52/100 and a GF Value™ of A$1.76 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Nobleoak Life's Research & Development for the six months ended in Dec. 2025 was A$0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.0 Mil.

Nobleoak Life  (ASX:NOL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Nobleoak Life Research & Development Related Terms

Nobleoak Life Research & Development Historical Data

* Premium members only.

The historical data trend for Nobleoak Life's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nobleoak Life Research & Development Chart

Nobleoak Life Annual Data
Trend Jun22 Jun23 Jun24 Jun25
Research & Development
0.00 0.00 0.00 0.00

Nobleoak Life Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ASX:NOL
52GF Score
Nobleoak Life Ltd ASX:NOL
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nobleoak Life Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of A$0.0 Mil mean?
Nobleoak Life (ASX:NOL) has a Research & Development of A$0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Nobleoak Life and its competitors.
Is Nobleoak Life's Research & Development too high?
Nobleoak Life's current Research & Development is A$0.0 Mil. Overall, Nobleoak Life has a GF Score™ of 52/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nobleoak Life's Research & Development compare to AFL and MET?
Nobleoak Life's Research & Development of A$0.0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Nobleoak Life and its competitors. Nobleoak Life's current Research & Development is A$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nobleoak Life stock overvalued right now?
Based on GuruFocus' analysis, Nobleoak Life (ASX:NOL) is currently considered Significantly Undervalued. The stock's GF Value™ is A$1.76, compared to a current price of A$1.19 — trading 32.7% below its estimated fair value. The current Research & Development is A$0.0 Mil. Nobleoak Life's overall GF Score™ is 52/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Nobleoak Life (ASX:NOL), the current Research & Development is A$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nobleoak Life (ASX:NOL) Overvalued in 2026?

Based on GuruFocus' analysis, Nobleoak Life stock appears to be undervalued. The current stock price of A$1.19 is trading 32.7% below its estimated GF Value™ of A$1.76. GuruFocus considers Nobleoak Life to be Significantly Undervalued.

Key valuation signals for ASX:NOL:

  • Research & Development: A$0.0 Mil
  • GF Value™: A$1.76 vs. price of A$1.19 (32.7% below fair value)
  • GF Score™: 52/100 with 2 warning signs

No single metric tells the full story. See the ASX:NOL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nobleoak Life Business Description

Address 44 Market Street, Level 4, Sydney, NSW, AUS, 2000
Nobleoak Life Ltd is involved in the manufacture and distribution of Life Insurance products (including death, total and permanent disability, trauma, income protection and business expenses insurance) through both its Direct and Strategic Partner (Advised) channels. The company's segments include Direct Business, Strategic Partnerships, and Genus. It generates maximum revenue from the Direct segment.
52GF Score

Get the complete analysis for ASX:NOL

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.19
Price
A$1.76
GF Value